United Therapeutics Corp at Goldman Sachs Global Healthcare Conference Transcript
Okay. Great. Well, thanks, everyone, for joining us for the afternoon session, really appreciate it. I'm Terence Flynn, one of the biotech analysts here at Goldman. We're very pleased to welcome United Therapeutics.
Joining us from -- today from the company, we have James Edgemond, CFO. James, thank you very much for being here, really appreciate you taking the time.
Great. Terence, thank you for the invitation to the conference. We've had really good meetings this morning, and I'm looking forward to continuing the conversation with you right here.
Questions & Answers
Great. Absolutely. Maybe just to get started, you could just give us an overview of your current PAH portfolio and maybe help us think about the forward growth drivers here for your marketed drugs as we think through kind of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |